Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
PolandStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
PolandStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PolandStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
PolandStudy of Atezolizumab and Tiragolumab for Patients with Unresectable Esophageal Squamous Cell Carcinoma After Chemoradiotherapy
PolandStudy of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
PolandStudy Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
PolandStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
PolandStudy on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
